Every week, we put a spotlight on one of the DigitalHealth.London Accelerator or Launchpad companies. Here’s a roundup of this month’s featured SME’s:
About: Lifelight is a game changing technology that allows any smartphone or tablet device to measure blood pressure, pulse and breathing rate simply by a patient looking into the device’s built-in camera for 40 seconds. Completely contactless, with no additional hardware needed, it saves NHS staff time while improving patient experience.
Recent success: Lifelight was recently classified as a Class 1 medical device (Class II pending) and are engaged with NICE and the NHS on how our 100% contactless technology can help fight COVID-19.
Lifelight measures the key vital signs which are critical to COVID-19 detection and avoids the need for healthcare staff to make contact with infected patients and cross-contamination of devices from infected patients to healthy patients. In short, Lifelight allows healthcare providers to test more people, quickly and safely.
Ask: Introductions to NHS Trusts for Lifelight First, intended for spot measurement of vital signs in clinical settings.
Learn more: https://lifelight.ai/ @xim_company
About: We are the developers of the Digital Health Passport – a Personal Health Record for young people with long term conditions, initially focused on asthma and allergies. The DHP supports care plans, remote symptom tracking and access to educational resources.
Recent success: Inclusion in the NHS Apps Library, accreditation for NHS login and selected by NHSX to receive Innovation and Technology Payments. Successfully overcoming governance hurdles to deliver a live system to the NHS in east London and now commissioned to integrate with Local Health & Care Records (LHCR) in Greater Manchester and Yorkshire & Humber.
Ask: Introductions to STP decision makers interested in integration of Personal Health Records with LHCRs to improve outcomes for young people with asthma and allergies. Connecting with NHS teams developing medium term responses to COVID-19 e.g. telephone review supported by digital care plans and remote symptom tracking.
Contact: email@example.com (Matt Bourne, Chief Technology Officer), firstname.lastname@example.org (Dr Greg Burch, Chief Clinical Information Officer), email@example.com (Paul S Weston, Strategic Partner Manager).
Learn more: https://tinymedicalapps.com @tinymedicalapps
About: Ampersand Health is a social purpose company, founded by doctors and patients to improve the health and happiness of people with long term inflammatory conditions.
The company is pioneering the development of behavioural- and data-science based digital therapy for people with immune-mediated diseases like Crohn’s, Colitis, Arthritis and Psoriasis.
Ampersand Health is recognised in the Digital Health Global 100, and has won the HSJ Award, the NHS Ideas Lab, the NHS Hackfest and competitive grants from government and industry. The company was selected for the 2018/19 PWC Scale Health programme and the NHS’s 2019/20 DigitalHealth.London accelerator.
Recent success: The launch of an app for at-risk IBD patients to manage health remotely which include expert-led self-care courses to help people with Crohn’s or Colitis improve their health and quality of life.
Ask: Introductions to stakeholders looking for remote monitoring solutions or longer-term solutions such as clearing the patient backlog and reducing hospital visits, particularly in Rheumatology and Gastroenterology
Learn more: ampersand.health @MyIBDCare